Ankur K Nagaraja
Overview
Explore the profile of Ankur K Nagaraja including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
1075
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Keller R, Mazor T, Sholl L, Aguirre A, Singh H, Sethi N, et al.
JCO Precis Oncol
. 2023 Jan;
7:e2200342.
PMID: 36634297
Purpose: With the growing number of available targeted therapeutics and molecular biomarkers, the optimal care of patients with cancer now depends on a comprehensive understanding of the rapidly evolving landscape...
2.
Singh H, Seruggia D, Madha S, Saxena M, Nagaraja A, Wu Z, et al.
Genes Dev
. 2021 Dec;
36(1-2):38-52.
PMID: 34969824
Barrett's esophagus (BE) and gastric intestinal metaplasia are related premalignant conditions in which areas of human stomach epithelium express mixed gastric and intestinal features. Intestinal transcription factors (TFs) are expressed...
3.
Wu Z, Zhou J, Zhang X, Zhang Z, Xie Y, Liu J, et al.
Nat Genet
. 2021 May;
53(6):881-894.
PMID: 33972779
Esophageal squamous cell carcinomas (ESCCs) harbor recurrent chromosome 3q amplifications that target the transcription factor SOX2. Beyond its role as an oncogene in ESCC, SOX2 acts in development of the...
4.
Nagaraja A, Kikuchi O, Bass A
Cancer Discov
. 2019 Nov;
9(12):1656-1672.
PMID: 31727671
Gastroesophageal adenocarcinomas (GEA) are devastating diseases with stark global presence. Over the past 10 years, there have been minimal improvements in treatment approach despite numerous clinical trials. Here, we review...
5.
6.
Li Q, Agno J, Edson M, Nagaraja A, Nagashima T, Matzuk M
PLoS Genet
. 2011 Oct;
7(10):e1002320.
PMID: 22028666
The transforming growth factor β (TGFβ) superfamily proteins are principle regulators of numerous biological functions. Although recent studies have gained tremendous insights into this growth factor family in female reproduction,...
7.
Nagaraja A, Middlebrook B, Rajanahally S, Myers M, Li Q, Matzuk M, et al.
Endocrinology
. 2010 Aug;
151(10):4994-5006.
PMID: 20739397
Inhibin-α knockout (Inha-/-) female mice develop sex cord-stromal ovarian cancer with complete penetrance and previous studies demonstrate that the pituitary gonadotropins (FSH and LH) are influential modifiers of granulosa cell...
8.
Creighton C, Benham A, Zhu H, Khan M, Reid J, Nagaraja A, et al.
PLoS One
. 2010 Mar;
5(3):e9637.
PMID: 20224791
MicroRNAs (miRNAs) are small non-coding RNAs that mediate post-transcriptional gene silencing. Over 700 human miRNAs have currently been identified, many of which are mutated or de-regulated in diseases. Here we...
9.
Creighton C, Fountain M, Yu Z, Nagaraja A, Zhu H, Khan M, et al.
Cancer Res
. 2010 Feb;
70(5):1906-15.
PMID: 20179198
MicroRNAs (miRNA) regulate complex patterns of gene expression, and the relevance of altered miRNA expression to ovarian cancer remains to be elucidated. By comprehensively profiling expression of miRNAs and mRNAs...
10.
Nagaraja A, Creighton C, Yu Z, Zhu H, Gunaratne P, Reid J, et al.
Mol Endocrinol
. 2010 Jan;
24(2):447-63.
PMID: 20081105
MicroRNAs (miRNAs) are small noncoding RNAs that direct gene regulation through translational repression and degradation of complementary mRNA. Although miRNAs have been implicated as oncogenes and tumor suppressors in a...